Michael O. Chaney

Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease

Alex E. Roher, Michael O. Chaney, Yu‐Min Kuo et al. · Journal of Biological Chemistry · 1996 · 507 citations · Full text

Life Sciences, Biochemistry, Neuroscience +17

Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis

Edward M. Johnstone, Michael O. Chaney, Franklin H. Norris et al. · Molecular Brain Research · 1991 · 313 citations

Life Sciences, Molecular Biology, Neuroscience +17

LY320135, a Novel Cannabinoid CB1 Receptor Antagonist, Unmasks Coupling of the CB1 Receptor to Stimulation of cAMP Accumulation

Christian C. Felder, Kelly E. Joyce, Eileen M. Briley et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 232 citations

Medicine, Cell Biology, Pharmacology +14

Structure of A23187, a divalent cation ionophore

Michael O. Chaney, Paul V. Demarco, Noel D. Jones et al. · Journal of the American Chemical Society · 1974 · 209 citations

Natural Sciences, Biochemistry, Chemistry +7

Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2-aminoethyl)pyrroles and 3- and 4-(2-aminoethyl)pyrazoles as dopamine agonists

Nicholas J. Bach, Edmund C. Kornfeld, Noel D. Jones et al. · Journal of Medicinal Chemistry · 1980 · 170 citations

Medicine, Medicinal Chemistry, Pharmacology +15